Journal of Clinical and Preventive Cardiology

EDITOR«SQ»S PAGE
Year
: 2021  |  Volume : 10  |  Issue : 1  |  Page : 1-

Editor's page January 2021


Ravi R Kasliwal 
 Editor-in-Chief, Journal of Clinical and Preventive Cardiology, Gurugram, Haryana, India

Correspondence Address:
Dr. Ravi R Kasliwal
Adjunct Professor Cardiology (NBE), Chairman, Clinical and Preventive Cardiology, Medanta-The Medicity, Sector 38, Gurugram - 122 001, Haryana
India




How to cite this article:
Kasliwal RR. Editor's page January 2021.J Clin Prev Cardiol 2021;10:1-1


How to cite this URL:
Kasliwal RR. Editor's page January 2021. J Clin Prev Cardiol [serial online] 2021 [cited 2021 Apr 21 ];10:1-1
Available from: https://www.jcpconline.org/text.asp?2021/10/1/1/312229


Full Text



With the dawn of the New Year, there is hope for the world, of redemption from the coronavirus-19 disease. It may still be far, but there is belief that with vaccination, relief may be around the corner, though there are roads to travel still. In many areas of the world, life is limping back to near normalcy. However, clearly, the three pillars of masking, distancing, and sanitizing will continue to be very much there. There is no questioning there.

The first original article “ECG Indices in Healthy Metabolic Syndrome Patients: Markers of Future CV Risk” written by Khushboo Agarwal and colleagues brings the whole arena of metabolic syndrome to a cardiologist because it details electrocardiographic criteria as markers of future risk. It is clearly an interesting read.

The second original article “Evaluation of Chemerin in Acute Coronary Syndrome and its Role in Cardiodiabetes” authored by Manoj Kumar and colleagues highlights the value of chemerin in the evaluation of patients presenting with acute coronary syndrome, particularly those who have diabetes mellitus. This article may well be a trend setter for the future.

The third article, an original research paper, titled “Echocardiographic Assessment of Right Ventricular Function in First Myocardial Infarction” written by Amar Prabhudesai and Kiron Varghese opens our eyes yet again not to ignore the right ventricle. The authors also emphasize the value of echocardiography in the management of sick patients.

The fourth article, an original contribution from across the seas, titled “Disordered Iron Homeostasis among Nigerians with Chronic Heart Failure: Pattern, Prevalence, and Clinical Correlates” authored by A. A. Akintunde and colleagues talks about a common deficiency that often accompanies heart failure and is associated with longer hospital stays and poor functional recovery. The entity is common across nations.

The fifth article – a review on Hypertension in sub-Saharan Africa – written by Jacques Joubert and colleagues is a must read for epidemiologists working on noncommunicable diseases (NCDs). In a sense, many countries where NCDs are increasing morbidity and mortality may find the commonality in their own areas or regions. I cannot resist quoting from the authors' introduction paragraph, a phrase from the United Nations' Secretary General Ban K-Moon “NCDs are a public health emergency in slow motion.”

The sixth article, a case report of a rare cyanotic disorder brings into focus the value of a wide knowledge base while treating sick patients. The authors B. Amirtha Ganesh and colleagues have done a commendable job.

The last article from two young clinical scientists titled “From COVID-19 to CARDEMIC: The Tsunami to Come” captures the very essence of this Journal. The Journal provides a platform for brilliant young minds to come forth and shake the scientific world. We see the truth in this article in everyday cardiology.

Hence, the current issue sets the tone for the New Year: 2021. This year brings light from the darkness of 2020. This Journal will be a torchbearer of hope, positivity, and better scientific knowledge for all.

Adieu, dear reader.